Cardinal Health Inc. (CAH)
Cardinal Health: Why This Essential Healthcare Distributor Deserves A Buy Rating
Cardinal Health receives a Buy rating, supported by defensive business fundamentals, strong adjusted EPS growth, and strategic expansion into specialty healthcare. CAH's Q3FY26 showed 11% revenue growth and 35% adjusted EPS growth, though GAAP results were pressured by higher costs and special items. Valuation is at a premium with a Forward P/E of 21.64x, justified by improving profitability and cash flow, but future upside depends on sustained margin gains.
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Cardinal Health (CAH) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why the Market Dipped But Cardinal Health (CAH) Gained Today
Cardinal Health (CAH) closed at $237.92 in the latest trading session, marking a +1.35% move from the prior day.
Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?
Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Cardinal Health (CAH) Ascends While Market Falls: Some Facts to Note
In the latest trading session, Cardinal Health (CAH) closed at $233.01, marking a +1.79% move from the previous day.
Here's Why Cardinal Health (CAH) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
CAH Stock Up Nearly 8% YTD: Will the Uptrend Continue in the Rest of 2026?
Cardinal Health has gained nearly 8% in 2026 as specialty pharma growth, rising EPS, and expanding healthcare services fuel investor optimism.
Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors
In the closing of the recent trading day, Cardinal Health (CAH) stood at $221.77, denoting a -1.99% move from the preceding trading day.
Is It Worth Investing in Cardinal (CAH) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Here's Why Cardinal Health (CAH) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
